Xuli Yang,Li Wang,Wenli Sai,Yin Cai,Juanjuan Gu,Xin Chen,Dengfu Yao. Clinicopathological features of hypoxia-inducible factor-1α and vascular endothelial growth factor expression in patients with lung cancer. Oncol Transl Med, 2016, 2: 261-267.
Clinicopathological features of hypoxia-inducible factor-1α and vascular endothelial growth factor expression in patients with lung cancer
Received:January 16, 2016  Revised:December 02, 2016
View Full Text  View/Add Comment  Download reader
KeyWord:lung cancer; hypoxia-inducible factor-1α (HIF-1α); nucleic acid metabolism; enzyme-linked immunosorbent assay (ELISA); diagnosis
Author NameAffiliationDepartment
Xuli Yang The Affiliated Hospital of Nantong University, Nantong 226001, China Research Center of Clinical Medicine
Li Wang Medical School of Nantong University, Nantong 226001, China Center of Medical Informatics
Wenli Sai The Affiliated Hospital of Nantong University, Nantong 226001, China Research Center of Clinical Medicine
Yin Cai The Affiliated Hospital of Nantong University, Nantong 226001, China Department of Oncology
Juanjuan Gu The Affiliated Hospital of Nantong University, Nantong 226001, China Research Center of Clinical Medicine
Xin Chen Nantong University, Nantong 226001, China School of Life Science
Dengfu Yao Research Center of Clinical Medicine, Affiliated Hospital of Nantong University
 
Research Center of Clinical Medicine
Hits: 6676
Download times: 7742
Abstract:
      Objective The aim of the study was to investigate the clinicopathological characteristics of hypoxiainducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) expression in patients with lung cancer. Methods Cancerous and noncancerous tissues were collected post-operation from 115 patients with lung cancers by the self-control method. Total RNA was extracted from the lung tissues. The status of tissue HIF- 1α expression and intercellular distribution was observed by immunochemistry using a tissue microarray. The expression levels of circulating HIF-1α and VEGF were detected by enzyme-linked immunosorbent assay (ELISA). Results The expression of serum HIF-1α [(138.3 ± 28.8) μg/L] in the group of patients with lung cancer was significantly higher (P < 0.01) than that in the group of patients with pneumonia [(58.8 ± 14.5) μg/L] and the control group of patients [(24.1 ± 3.3) μg/L]. There was a strong positive correlation of serum HIF-1α levels (r = 0.937, P < 0.01) with serum VEGF levels. The specific concentration of total RNA [(1.52 ± 1.14) μg/mg wet lung tissues] in the cancerous tissues was significantly higher (t = 8.494, P < 0.001) than that in the noncancerous tissues [(0.58 ± 0.33) μg/mg]. The clinicopathological features of HIF-1α expression in lung cancer tissues revealed a significant relationship between positive HIF-1α expression and patient sex (χ2 = 4.494, P = 0.034), tumor size (χ2 = 4.679, P = 0.031), differentiation degree (χ2= 8.846, P = 0.012), and presence of lymphatic node metastasis (χ2= 6.604, P = 0.037). Conclusion Abnormal HIF-1α expression in lung cancer is closely related with nucleic acid metabolism and angiogenesis, and it may be helpful in the diagnosis and identification of lung cancer.
Close